Odevixibat treatment in a child with hypoplastic left heart syndrome and severe cholestatic pruritus: a case report
Liver-related abnormalities are commonly observed in patients with congenital heart disease, and these may lead to secondary manifestations such as pruritus. Odevixibat is an ileal bile acid transporter inhibitor under investigation for the treatment of cholestatic liver diseases. Here, we describe...
Saved in:
Main Authors: | Rainer Ganschow, Christof Maucksch, Peter Rauschkolb, Martin B. E. Schneider |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2024.1443338/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathophysiological mechanisms, multidimensional diagnostics and modern therapies of pruritus in pancreatic cancer: review and perspectives
by: Jagienka Agata Włodyka, et al.
Published: (2025-01-01) -
First report of hypoplastic left heart syndrome in 3p- syndrome and review of candidate genes
by: Ana Kalise Böttcher, et al.
Published: (2025-01-01) -
Evaluation of the Frequency and Pathological Diagnosis of Vulvar Lesions Is it Associated with Vulvar Pruritus - If So, How Closely?
by: Omer Demir, et al.
Published: (2021-12-01) -
The burden of Alagille syndrome: uncovering the potential of emerging therapeutics – a comprehensive systematic literature review
by: Philip Bufler, et al.
Published: (2025-01-01) -
A 19-year-old Patient with Recurrent Pruritus and Jaundice
by: K. S. Nezhdanov, et al.
Published: (2023-09-01)